Correction by unknown
SUPPRESSION OF THE IMMUNE RESPONSE BY
a-FETOPROTEIN
II . The Effect of Mouse a-Fetoprotein on Mixed Lymphocyte
Reactivity and Mitogen-Induced Lymphocyte Transformation*
By ROBERT A . MURGITA ANDTHOMAS B. TOMASI, JR .
(From the Department of Immunology, Mayo Medical School, Rochester, Minnesota 55901)
The synthesis of a-fetoprotein (AFP)' is associated with the processes of normal,
restorative, and malignant growth as reflected by its synthesis by the fetal liver
during embryogenesis, its expression during hepatic regeneration after various
forms of injury (1-3), and its appearance in the sera of certain tumor-bearing
hosts, most notably in primary hepatocellular carcinomas (4, 5) and malignant
teratoblastomas (6) . The use of more sensitive methods of detection have
subsequently demonstrated abnormally high levels of AFP in several nonmalig-
nant diseases (7-9) as well as malignant diseases (10-12) . While much is now
known about the pathological distribution of AFP and its potential diagnostic
importance, the functional significance of AFP and the mechanisms involved in
regulating its synthesis during ontogenesis and pathogenesis are not understood .
In the preceding article (13), we have proposed that AFP has an immunoregula-
tory function based on our demonstration that this protein, either in the isolated
form or as it occurs in amniotic fluid, exerts a noncytotoxic immunosuppressive
effect on the primary and secondary antibody response . In the present study we
extend this concept by demonstrating that AFP suppresses certain T-cell-
dependent functions such as allogeneic and mitogen-induced lymphocyte trans-
formation.
Materials and Methods
Animals .
￿
CBA/J and BALB/c mice, purchased from Jackson Laboratories, Bar Harbor, Maine,
were used in all experiments . Pregnant HA/IRC mice, bred locally at the Mayo Clinic, were used as a
source of amniotic fluid (MAF) .
* This investigationwassupported in part by U. S . Public Health Service Research GrantRO1AM
17554 from the National Institute of Arthritis and Metabolic Diseases, and the American Cancer
Society .
'Abbreviations used in this paper: AFP, a-fetoprotein ; Con A, concanavalin A; GVH, graft-vs .-
host ; HAA, hepatitis-associated antigen ; IRA, immunoregulatory alpha globulin ; LPS, lipopolysac-
charide ; MAF, mouse amniotic fluid ; PHA, phytohemagglutinin ; SI, stimulation index .
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Antisera . Antiserum to MAF was prepared in rabbits by subcutaneous injection of MAF
supplemented with Freund's complete adjuvant as previously described .Theantiserumwas rendered
specific for AFP by absorption with lyophilized normal adult mouse serum.
Isolation ofMouseAFP, Albumin, and Transferrin.
￿
MAFwascollected from HA/IRC mice in the
late second or early third trimester of pregnancy as described elsewhere (13) . Approximately 1 ml of
fluid was collected form each pregnant mouse. AFP was isolated from pooled fluid by a two-step
procedure of antibody-agarose affinity chromatography (14) followed by preparative polyacrylamide
gel electrophoresis (15) . MAF waspassed over an affinity column consisting of the -y-globulin fraction
of a rabbit antimouseserum coupled by cyanogen bromide-activated Sepharose 4B (Pharmacia Fine
Chemicals, Inc., Piscataway,N. J.) to selectively remove serum components . PureAFPwas obtained
by applying the fall-through (nonretained protein) of the affinity column to a Shandon model
SAE-2782 preparative disc electrophoresis apparatus (Shandon Scientific Co ., London, England) as
previously described (13) . The criteria of purity was a single band on analytical disc gel
electrophoresis (16, 17) and a single precipitin arc on gel diffusion and immunoelectrophoresis using
antiwhole amniotic fluid . Mouse transferrin and albumin were isolated from pooled normal mouse
serum by a two-step procedure of Geon-Pevikon block electrophoresis followed by sucrose density
gradient isoelectric focusing (18) .
MixedLymphocyte Reactions .
￿
One-waymixed lymphocyte reactions were performedby treating
BALB/c spleen cells at adensity of 100 x l0e/5 ml with 25 gg mitomycin C/ml cell suspension as de-
scribed by Peck and Bach (19) . After an incubation of 30 minat 37 °C the cells were washed twice in
cold Hanks' balanced salt solution, incubated again for 10 minat 37°C, andwashed before placing the
mitomycin-treated cells in culture . Stimulator spleen cells (mitomycin-treated BALB/c) were sus-
pended in RPMI 1640 medium (Grand Island Biological Co ., Grand Island,N. Y .) supplemented with
penicillin (50 U/ml), streptomycin (50 ug/ml), and L-glutamine (200 mM, 2 ml/100 ml of medium).
Respondor spleen cells (CBA/J) were suspended in thesame medium plus 10% fetal calf serum which
had been heated at 56°C for 30 min. All tissue culture medium ingredients were obtained from
GIBCO. Mixed lymphocyte cultures contained 2 x 106 respondor cells plus 5 x 106 stimulator cells
in 0.2 ml of medium in flat-bottom Micro-Test tissue culture plates (Falcon Plastics, Div. of BioQuest,
Oxnard, Calif'.) . Control cultures contained cells from either source alone . Three replicates of each
cell type or combination were done . Preparations to be tested for immunosuppressive activity were
added in 0.02 ml at the start of culture . Plates were incubated in a humidified 5% CO,-95% air at-
mosphere for 72 h. 1 gCi of tritiated thymidine ([ 3H]TdR; 2 Ci/mmol; New England Nuclear, Bos-
ton, Mass .) was added for the last 12 h of culture . The cells were harvested using a microculture
harvesting device, placed in 2-3 ml of aquasol (New England Nuclear) and the trichloroacetic acid
insoluble radioactivity measured in a liquid scintillation spectrometer . The arithmetic mean of the
triplicate samples was determined and the results are expressed as counts per minute . Thestimula-
tion index (SI) is calculated by dividing thecounts perminute in mixed cultures by the sum of counts
per minute in cultures of each cell type alone .
Mitogen Reactivity .
￿
BALB/c or CBA/J spleen cells were cultured to assay for reactivity to the
mitogens phytohemagglutinin (PHA), concanavalinA(Con A),and lipopolysaccharide (LPS)usinga
microculture system as previously described (20) . 1.75 x 10 6 spleen cells were cultured in triplicate in
0.1 ml of RPMI 1640 supplemented as described above . 0.1 ml of purified PHA (Wellcome Reagents
Limited, Beckenham, England) in concentrations of 4.5 and 9.0 jug/ml, 0.1 ml Con A (two times
crystallized, Nutritional Biochemical Corp ., Cleveland, Ohio) in concentrations of 4.5 and 9.0 jug/ml,
and 0.1 ml LPS (LPS from Escherichia coli 0127, Difco Laboratories, Detroit, Mich .) in
concentrations of 15.7, 31 .25, and 62.5 jug/ml, or medium only was added . Preparations to be tested
for immunosuppressive activity were added in 0.02 ml at the start of culture . The cell cultures were
incubated in flat-bottom plates in a humidified atmosphere of 95% air and 5% CO, for 48 h. 1uCi of
[9H]TdR was added for the last 12 h of culture and the cells were harvested and the amount of
radioactivity incorporated into acid-precipitable material was determined as described above .
Results
Effect of Mouse Amniotic Fluid and Its Isolated Protein Component on
Mitogen Reactivity . Initial experiments showed that MAF effectively sup-442
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pressed the DNA synthesis of normal BALB/c spleen cells cultured in the
presence of various concentrations of PHA, Con A, and LPS. MAF did not
suppress the amount of ['H]TdR incorporation of cells cultured in medium alone
which demonstrated an absence of cytotoxicity of MAF for the cultured
lymphocytes . This is consistent with our previous study (13) in whichMAF and
AFP had no significant effect on the cell viability of cultured lymphocytes . As
shown in Table I,MAF inhibitedPHA stimulation by 85%, ConAstimulation by
70%, and LPS stimulation by 80% . Thus, MAF contains a factor(s) which is
highly suppressive for the T-cell-dependent mitogenic effect of PHA and Con A
on splenic lymphocytes . Since it is generally considered that LPS can be used as
TABLE I
Suppression of Mitogen-Induced Lymphocyte Transformation by Mouse AFP*
* Spleen cells from adult CBA/J mice were cultured at 1 .75 x 10' cells/0.2 ml in the presence of
optimal mitogenic concentrations of PHA (4 .5 kg/ml), Con A (4 .5 ug/ml), or LPS (31 .25 Ag/ml) .
DNA synthesis was measured by the incorporation of [3H]TdR and is expressed as the mean of
triplicate cultures ± the standard error of the mean (SE) .
$Final concentration in the culture .
a functional marker of B-cell reactivity (21), there also appears to be suppressive
activity inMAF forB cells although the specificity ofLPS forB cells has recently
been questioned (see Discussion) .
To determine whether the immunosuppressive activity was associated with
one of the three major protein components of MAF (albumin, transferrin, and
AFP), these proteins were added to cultures individually in the isolated form .
AFP was isolated from pooled MAF; however, insufficient amounts of albumin
and transferrin for testing could be obtained from this source . For this reason,
and also because the adult-type plasma proteins found in amniotic fluid are
reported to be almost entirely of maternal origin (22), the albumin and
transferrin used in this study were obtained from normal mouse serum. The
results in Table I show that isolated AFP was highly suppressive for mitogen-
stimulated cells . There was no significant effect of AFP on cultures to whichjust
media or normal mouse serum were added . Equivalent amounts of albumin also
suppressed but to a much smaller extent, whereas transferrin had a stimulatory
effect that was particularly evident in the cells cultured in medium alone .
Preparation
No .
stimulant
PHA
[9H]TdR incorporation
Con A LPS
mean cpm±SEM
Control (media) 829±50 37,7891285 40,73511,407 29,4811950
MAF 950178 6,432±1,115 12,126±750 600±95
AFP(200 Ag/ml)$ 720±34 2,903±260 3,5921595 515±60
Albumin (200 Ag/ml) 885±150 26,540±1,540 25,920±1,980 19,610±2,800
Transferrin 1,225±260 38,553±4,100 53,366±5,670 28,034±1,125
(200,g/ml)
Normal mouseserum 790±65 38,149±2,410 47,104±1,550 23,682±955
(200,ug/ml)ROBERT A . MURGITA AND THOMAS B . TOMASI, JR .
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The results of dose-response studies with pure AFP, transferrin, and albumin
on mitogen reactivity are listed in Table II . The suppressive activity of pure AFP
diminished linearly over the 100-fold dilution range; however, suppression was
still evident with a concentration of 1 jAg/ml . In the experiment shown there was
some depression of [9H]TdR incorporation in media control cultures to which the
higher concentrations ofAFP were added . The reason for this is not clear since it
was only noted when the background count in media control was relatively high
and was not observed in other experiments where the background counts in the
TABLE II
Dose-Response Effect of Mouse AFP, Albumin, and Transferrin on Mitogen-Induced
Lymphocyte Transformation*
* Spleen cells from adult CBA/J mice were cultured at 1.75 x 10" cells/0 .2 ml in the presence ofoptimal mitogenic
concentrations of PHA (4 .5 ug/ml), Con A (4 .5 ug/ml), or LPS (31.25 ug/ml) .DNA synthesis was measured by the
incorporation of ['H ]TdR and is expressed as the mean of triplicate cultures = the standard error of the mean
(SE) .
$Final concentration in the culture .
media controls were low and higher concentrations of the protein were added
(Table I) . The AFP preparation did not affect cell viability as measured by the
ability of cells to exclude trypan blue . Perhaps the effect is due to suppression by
AFP of proliferation oflymphocytes by stimulatory factorspresent in the batches
of fetal calf serum which give a high background count . The suppressive effect
observed with 200 jag/ml of albumin (Table I) was lost when the preparation was
diluted to 100 leg/ml and lower concentration appeared to be slightly stimulatory.
Transferrin retained its augmenting effect at all concentrations tested . In
experiments to be reported in more detail elsewhere' we have shown that the
stimulatory effect of transferrin on mixed lymphocyte reactivity is optimal at a
concentration of approximately 50 gg/ml and augmentation diminishes as the
amount of transferrin is increased or decreased from this optimal level . These
results demonstrated that AFP was highly suppressive, albumin was slightly
z Murgita, R. A., and T . B . Tomasi, Jr . The effect of normal serum proteins on the immune
response . Manuscript in preparation .
Preparation No .
stimulant
PHA
1'H ]TdR incorporation
Con A LPS
mean cpm =SE
Control (media) 2,9481327 40,58215,625 45,02017,223 28,385=1,860
AFP (100 ug/ml)t 827172 7,0451962 12,739 i=675 1,213=179
AFP (50 ug/ml) 1,4321137 8,817=3,305 13,33114,677 2,1381154
AFP (10 kg/ml) 1,541=359 15,6411342 22,328 8,466=562
AFP (1 jig/ml) 2,383=130 26,658=2,239 33,932=1,335 17,878=875
Albumin (100kg/ml) 4,923=853 40,106=4,527 43,588=261 29,393=2,979
Albumin (10 ug/ml) 5,648=163 44,453=2,619 49,526=5,035 35,915 :1:3,818
Albumin (1 ug/ml) 4,820-369 49,179=2,387 53,029=14,000 31,412=3,747
Transferrin (100)Ag/ml) 8,940=1,415 47,493=5,728 62,306=8,669 35,843=333
Transferrin(10ug/ml) 6,574=327 48,351=2,092 61,638=1,811 46,238
Transferrin (l ug/ml) 5,13511,798 50,690=5,674 56,929=284 34,777=4,668444
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suppressive at the highest concentration tested (200 Eug/ml), and that transferrin
had a stimulatory effect on B- and T-cell-dependent mitogen reactivity .
Suppression and Augmentation of the Mixed Lymphocyte Reaction by MAF
and Its Isolated Protein Components .
￿
Shown in Table III are the results of a
dose-response effect ofMAF on CBAsplenic lymphocyte proliferation in cultures
stimulated with mitomycin-treated BALB/c spleen cells . DNA synthesis in
unstimulated cultures of CBA respondor cells alone was increased in cultures
containing all but the highest dilution of MAF. The augmenting effect
diminished as the MAF was diluted and disappeared at a 1/110 dilution .
TABLE III
Dose-Response Effect ofMAF on the Mixed Lymphocyte Reaction
* Mitomycin C treated (stimulator cells) .
$Final dilution ofMAF in the culture .
However, the degree of suppression of the allogeneic mixture remained relatively
constant over the 500-fold dilution range of MAF. The combination of the
suppressing and augmenting effects ofMAF resulted in an almost linear increase
of the SI with decreasing amounts of MAF added to the cultures . Therefore,
observations of the SI's alone indicated a suppressive effect ofMAF on mixed
lymphocyte reactivity which decreased proportionally to decreasing amounts of
MAF in the culture . However, the individual counts per minute of the respondor
cells and the allogeneic mixture more accurately reflected thatMAF exerted both
augmenting and suppressing effects on the cultures . Experiments comparingthe
effects of dialyzed vs . undialyzed MAF suggested that part of the augmenting
activity ofMAF was dialyzable .
The results shown in Table IV demonstrated that isolated AFP was highly
CBA BALB/c* Preparation
Mean 72 h
cpm t SE
SI
2 x 108 0 845t122
2 x 108 5 x 10 8 Media 4,7541568 4 .8
0 5 x 108 147f35
2 x 10 8 0 3,0081488
2 x 10 8 5 x 10 8 MAF (1/12)$ 2,4421355 0.7
0 5 x 108 500172
2 x 10 8 0 1,5001196
2 x 108 5 x 108 MAF(1/55) 2,6961210 1.6
0 5 x 10 8 185f47
2 x 10 8 0 966t145
2 x 10 8 5 x 10 8 MAF (1/110) 2,181t355 1 .9
0 5 x 10 8 168141
2 x 10 8 0 454 ::E 187
2 x 10 8 5 x 10 8 MAF (1/550) 2,5471342 4.3
0 5 x 10 8 133138ROBERT A MURGITA AND THOMAS B. TOMASI, JR .
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TABLE IV
Suppression of the Mixed Lymphocyte Reaction by Purified MouseAFP
* Mitomycin C treated (stimulator cells) .
$Final concentration in the culture .
suppressive, albumin inhibited at 200 ug/ml but not at 100 jug/ml, and that
transferrin exerted an augmenting effect on the mixed lymphocyte reaction . As
demonstrated in Table V, AFP strongly inhibited the mixed lymphocyte reaction
at 100 and 10 jug/ml and was still slightly suppressive at a concentration of 1
ug/ml . In general, therefore, the effects of AFP and the other constituents of
MAF on mixed lymphocyte reactivity are similar to the effects of these same
proteins on mitogen-induced lymphocyte transformation.
Discussion
AFP, in concentrations comparable to those we have shown to suppress antibody
synthesis (13), effectively inhibits normal splenic lymphocyte stimulation by
T-cell mitogens (PHA and Con A), a presumed B-cell mitogen (LPS), and
mitomycin-treated allogeneic spleen cells in a one-way mixed lymphocyte
reaction . Dose-response studies demonstrated that APP was still suppressive at 1
ug/ml . The addition of MAF, shown previously to contain approximately 36%
albumin, 50% AFP, and 14% transferrin (13), also inhibited allogeneic and
mitogen-induced lymphocyte transformation . However, a simple quantitative
CBA BALB/c* Preparation
Mean 72 h
cpmtSE
SI
2 x 10 6 0 780198
2 x 10 6 5 x 10 6 Media 3,8461121 4.31
0 5 x 10 6 111125
2 x 10 6 0 5501110
2 x 10 6 5 x 10 6 AFP (200ug/ml) 301186 0.46
0 5 x 106 95121
2 x 10" 0 355175
2 x 106 5 x 106 Albumin (200ug/ml) 1,3511112 2.10
0 5 x 10 6 287156
2 x 10 6 0 22718
2 x 10 6 5 x 10 6 Albumin (100ug/ml) 3,074 1234 7.51
0 5 x 10 6 182f45
2 x 10 6 0 514145
2 x 10 6 5 x 10 6 Transferrin (200 ug/ml) 6,9651327 10,29
0 5 x 106 16310
2 x 10 6 0 717 156
2 x 10 6 5 x 106 Normal mouseserum (200ug/ml)$ 3,2391787 3.63
0 5 x 106 175137446
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TABLE V
Dose-Response Effect of Mouse AFP on the Mixed Lymphocyte Reaction
* Mitomycin C treated (stimulator cells) .
$ Final concentration in the culture .
comparison between the suppressive effects of isolated AFP with an equivalent
amount ofMAF was not possible because of the presence of stimulatory factor(s)
also present inMAF (Table III) . The basisof the augmenting effect ofMAF is not
known ; however, it was only partly removed by exhaustive dialysis ofMAF . The
nondialyzable augmenting factor may be transferrin since this protein, when
isolated, had a significant stimulatory effect onDNA synthesis in control as well
as mitogen and allogeneically stimulated cultures . Albumin, at a concentration
of 200 A,g/ml, partially inhibited mitogen stimulation (Table 1) and the mixed
lymphocyte reaction (Table IV) ; however, this effectwas no longer evident at 100
itg/ml, in fact, lower concentrations appeared to be slightly stimulatory . It is not
entirely clear whether the effect ofLPS on mouse lymphocytes is exclusively on B
cells as originally reported (23, 24) or ifT cells may also be involved . Recent data
(25) suggest that the mitogenic effect of LPS on B cells may require the
participation ofT cells . Therefore, it is difficult to be certain at this time if the
suppressive effect of AFP on LPS stimulation isdue toa direct effect ofAFP onB
cells or whether it is acting via a T cell .
An a-globulin fraction isolated from normal plasma has been shown to
suppress several T-cell-mediated immune reactions, including graft rejection
(26), the elaboration of macrophage immobilization factor (27), lymphocyte
transformation induced by PHA and allogeneic stimulation (28), and sheep
erythrocyte rosette formation with human lymphocytes (29) . It is suggested that
the immunosuppressive a-globulin (termed immunoregulatory a-globulin or
IRA) represents a naturally occurring feed-back control mechanism which exists
CBA BALE/c* Preparation Mean 72 h
cpm t SE S1
2 x 101 0 505 t 64
2 x 101 5 x 10 1 Media 3,027 + 152 5.07
0 5 x 10 1 92 f 14
2 x 10 1 0 609 t 192
2 x 101 5 x 101 AFP (100 ug/ml)$ 1,136 t 270 1.59
0 5 x 10 1 103 t 13
2 x 10 1 0 372 t 63
2 x 10 1 5 x 10 1 AFP(10ug/ml) 1,972 t 129 3.73
0 5 x 10 1 156 t 73
2 x 10 1 0 559 t 88
2 x 10 1 5 x 101 AFP (1 ug/ml) 2,313 t 225 3.29
0 5 x 10 1 144 10
2 x 10 1 0 662 t 97
2 x 10 1 5 x 10 , AFP (0.1 jug/ml) 2,847 f 163 3.77
0 5x 10 1 93 t 7ROBERT A. MURGITA AND THOMAS B. TOMASI, JR .
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to regulate T-cell-dependent immune reactions (29) . Sincethe active fractions of
IRA contain primarily a,- and a 2-globulins (28, 29) and sinceAFP is present in
normal adult sera (3) it has not been excluded that the suppressive effects
observed with IRA preparations are partly due to low levels of AFP in these
fractions. However, recent studies (30) suggest that the active moiety ofIRA is a
peptide which is noncovalently bound to proteins with an electrophoretic
mobility in the a-region . Although our findings do not exclude the possibility ofa
suppressive peptide tightly bound to AFP, for reasons previously discussed (13)
we believe that AFP is not serving as a carrier and is probablynotrelated to IRA.
The synthesis of AFP is a normal physiological event during embryonic
development, and if this glycoprotein has immunoregulatory activity as we
postulate, it may serve as a natural mechanism to protect the fetus from the
potentially harmful effects of the maternal immune mechanism . There appears
to be no intrinsic defect in the maternal cellular immune mechanism in most
reports (31, 32). Moreover, there is some evidence (33) for an extrinsic factor
present in maternal serum which has an inhibitory effect on the response of
normal adult lymphocytes to nonspecific mitogen stimulation and the authors
noted a positive correlation between the level of AFP and the inhibitory activity
in the fetal plasma . Therefore, further studies would be in order to determine
whether the lowered maternal cell-mediated immunity during pregnancy mani-
fested by impaired lymphocyte responses to nonspecific mitogen (34, 35),
infectious agents (36), and homografts (37) may result, at least in part, from
immunosuppression levels of AFP .
Although it is known that the mammalian fetus is capable of expressing an
active immunological response to certain antigenic stimuli in utero (38),
numerous studies have demonstrated a reduced capacity of the fetus and
newborn to respond immunologically (reviewed in 39) . The gradual acquisition of
full immunological responsiveness by the fetus certainly depends on quantitative
changes in the lymphoid cell populations required for the immune response .
However, in addition, there is evidence which suggests that the cellular
constituents necessary to initiate an immune response are present in the
developing young before active immune reactivity normally occurs . In mice, B
cells, T cells, and antigen-binding cells all appeared in the fetal spleen at about
15-16 days of a 19-day gestation period and their numbers increased rapidly
reaching a plateau by 1 wk after birth (40) . However, the capacity to response to
antigen did not arise until about 2wk after birth despite the fact that there were
no quantitative changes in the total numbers of T, B, and antigen-binding cells
between 1 and 2wk of age. Other studies have shown that while neonatal thymus
cells are poorly responsive to ConA stimulation, adult thymocytes are markedly
stimulated by this mitogen, despite the fact that both neonatal and adult mice
possess similar numbers and frequency of 0-bearing cells (41) . Full reactivity to
Con A is only achieved after the first 3wk of life . Although these results can be
interpreted as indicating the necessity forsubtle pre- and postnatal maturational
events necessary for the full development of immune capacity, they are also
consistent with the presence of a fetal and neonatal circulating suppressive
factor(s) . Appropriate to this point is an earlier report by Dixon and Weigle (42)
demonstrating the relatively poor immune response of sensitized adultlymphoid448
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cells when transferred to neonatal recipients whereas such cells were capable of
strong antibody responses when transferred to X-irradiated adult recipients . The
authors suggested that the neonatal rabbit did not offer the transferred
immunocompetent adult cells an "environment" conducive to antibody forma-
tion . Conversely, they showed that while immune cells from neonatal rabbits did
not function optimally in antibody formation in their natural environment, they
did when transferred to X-irradiated adult recipients (43) .
Fetal cells have been reported (44) to undergo cellular reactions and this has
been cited as important in preventing graft-vs.-host (GVH) reactions from
transmitted maternal cells. Although this may be valid, an alternate explanation
is that the fetal cells have been removed from the suppressive effects of AFP
during isolation and washing . Moreover, it is conceivable that both fetal and
transmitted maternal cells are simultaneously suppressed in vivo, thus prevent-
ing the development of a GVH reaction . According to this hypothesis, after birth
as theAFP concentration decreases and immune reactivity appears, transmitted
maternal cells would then be rejected . This thesis suggests several experimental
approaches such as studies of the time of rejection of transmitted maternal cells
and the relative sensitivity of fetal vs . maternal lymphocytes to suppression by
AFP . For example, if fetal lymphocytes escape suppression at higher concentra-
tions ofAFP than maternal cells this would lead to the rejection of maternal cells
at the point in development (either before or after birth) when the AFP levels
dropped to a critical level . Other survival advantages to the fetus and young
neonates of immune suppression during ontogenetic development have already
been discussed (13) .
Serum factors which inhibit lymphocyte transformation in vitro in response to
nonspecific mitogens and/or specific antigens have been described in a number of
pathological conditions (45) which include ataxia telangiectasis (46), hepatitis
(47-49), alcoholic and primary biliary cirrhosis (50, 51), and gastrointestinal
cancer (52) . This group of pathological conditions is of particular interest here
since abnormally high AFP levels have been reported in most of these diseases
(7-11) . Based on our demonstration of the immunosuppressive activity of AFP,
we postulate that AFPmay be one, and possibly an important factor causing the
nonspecific immune suppression reported in many of the diseases mentioned
above. Furthermore, as we have stated before (13) and stress here, it is possible
that local immune suppression in the absence of elevated serum levels of AFP
could be caused by the production of suppressive concentrations of AFP within
and around the microenvironment of the disease process (i.e ., proliferating tumor
cells) . The presence of extremely low (nanogram) levels of AFP in normal adult
sera (53) together with our demonstration that AFP is immunosuppressive in
vitro at concentrations of the order of 1 lag/ml makes the suggestion tenable that
immune suppression accompanying certain diseases may be attributable to
functionally significant levels of AFP at the local level .
The fact that AFP reappears in postnatal life with regularity in association
with certain malignant diseases (4-11) has led to its classification as a
tumor-associated embryonic antigen (54) . At present at least three situations are
known to exist showing a relationship between the occurrence of unusually high
AFP levels with subsequent development of malignancy . Firstly, in differentROBERT A. MURGITA AND THOMAS B. TOMASI, JR .
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strains of mice an association between the level of AFP in adult serum and
susceptibility to spontaneous and carbon tetrachloride-induced hepatomas has
been noted (3). Secondly, in humans an association has been reported between
an abnormal thymus, immune deficiency, and malignancy in patients with
ataxia telangiectasia (55), and in one report (9) all patients had raised serum
AFP concentrations. Thirdly, it has been suggested (56) that cell-mediated
immunity is an important factor in determining the clinical course of the liver
disease associated with the presence of Australian or hepatitis-associated antigen
(HAA). It has been postulated that viral hepatitis associated with HAA can
progress through postnectoric cirrhosis to the development of hepatomas and
there is a tendency for HAA-positive individuals with hepatocellular carcinoma
to be AFP positive and to have underlying cirrhosis (57) . These circumstances are
consistent with a relationship between AFP, the persistence of HAA, depressed
cellular immunity, and its progression to cirrhosis and/or malignant disease. We
recognize fully that the intriguing suggestions raised above concerning the role of
AFP in normal development and in certain disease states are at present
speculative but hope that they will stimulate further investigation of these
potentially important interrelationships.
a-fetoprotein (AFP), both in the isolated form and as it occurs in amniotic fluid,
was shown to suppress the mitogenic effects of phytohemmaglutinin, con-
canavalin A, and lipopolysaccharide on mouse spleen cells and to inhibit
allogeneic lymphocyte stimulation in the one-way mixed lymphocyte reaction.
Dose-response experiments demonstrated that the suppression effect of AFP on
the response to mitogens and to allogeneic cells diminished linearly with
inhibitory activity still evident at 1 lag/ml . There was no significant effect of AFP
on control cultures to which media alone was added and the cell viabilities of
cultures containing mouse amniotic fluid (MAF) or AFP did not differ from
control cultures. Unfractionated MAF had in addition to suppressive activity, a
stimulatory effect on lymphocyte reactions in vitro which was particularly
evident in the mixed lymphocyte reaction . The augmenting activity in MAF was
partly removed by dialysis . The addition of mouse transferrin to the cultures had
a stimulatory effect whereas albumin was slightly suppressive at 200,ag/ml but
not at lower (< 100 fag/ml) concentrations . Since, in addition to AFP, albumin
and transferrin are the two major protein components of MAF it is concluded
that the suppressive activity of MAF is attributable to AFP while the stimulatory
activity is due in part to low molecular weight (dialyzable) factors and in part to
transferrin. The results of this investigation are discussed in terms of the concept
that AFP has an immunoregulatory function in vivo.
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